Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?

Business
Nov.12
Special Report|Japan Tobacco Buys CLEW: Can Its 160,000-Store Cigarette Network Help It Vie for U.S. Nicotine Pouch Share Against PMI and BAT?
Japan Tobacco Inc. (JT) announced on November 12, 2026, that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., including trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). CLEW, currently distributed through selected outlets in 13 U.S. states, will immediately join the JTI LIGGETT portfolio. The transaction follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024. JTI LIGGETT says its existing cigarette brands reach more than 160,000 U.S. retail stores. During the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouches in the United States. Although Nevcore previously announced FDA acceptance of CLEW's PMTA, the brand is absent from the agency's current list of authorized nicotine pouch products. JT has not disclosed a retail expansion plan for CLEW.

Key Points

Acquisition: JT acquired CLEW's U.S. assets on November 10, including trademarks, intellectual property, product formulations and a PMTA. Financial terms were not disclosed.

U.S. Operations: JT completed its approximately $2.4 billion Vector Group acquisition in October 2024. JTI LIGGETT says its cigarette brands are present in more than 160,000 U.S. stores, with over 8% market share.

Category Expansion: At the 2026 NACS Show in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet introduced nicotine pouch products in the United States.

Regulatory Status: Nevcore announced FDA acceptance of CLEW's PMTA in 2024, but CLEW is not among the 67 nicotine pouch products authorized by the FDA as of November 12.

Next Steps: CLEW is distributed through selected outlets in 13 states. JT has not announced whether or when it will expand the brand through JTI LIGGETT's existing retail network.


2Firsts November 12, 2026

Japan Tobacco Inc. (JT) said on November 12 that it had acquired the U.S. assets of nicotine pouch brand CLEW from Nevcore Innovations Inc., adding a brand already distributed through selected outlets in 13 states to the JTI LIGGETT portfolio. The transaction includes trademarks, intellectual property, product formulations and a Premarket Tobacco Product Application (PMTA). Financial terms were not disclosed.

The deal follows JT's approximately $2.4 billion acquisition of U.S. cigarette maker Vector Group in 2024, which expanded the Japanese company's cigarette operations and distribution network in the United States.

JTI LIGGETT says its existing cigarette brands are present in more than 160,000 retail stores nationwide and account for over 8% of the U.S. cigarette market.

At the 2026 NACS Show in Las Vegas in October, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States. Just over a month later, JT announced the acquisition of CLEW, a brand with existing products, retail distribution and a PMTA asset.

JT has not announced whether or when CLEW will be introduced through its established U.S. retail network.

JT Acquires CLEW's U.S. Assets, Adding Brand to JTI LIGGETT Portfolio

According to JT's announcement, the transaction closed on November 10, 2026, and covers only U.S. assets, including CLEW trademarks, intellectual property rights, product formulations and a PMTA.

The company did not specify whether manufacturing facilities, inventories, retail contracts or other operating assets were included.

CLEW was previously owned by Nevcore Innovations Inc., a U.S. company operating in next-generation nicotine products. The brand offers moist, tobacco leaf-free nicotine pouches in various flavors and strengths.

JT said CLEW is currently distributed through selected outlets in 13 U.S. states. It did not identify those states or disclose the number of retail outlets, sales volume or revenue.

Following the acquisition, CLEW will immediately become part of the JTI LIGGETT portfolio.

Idil Yasa, JTI's Regional President for the Americas, linked the purchase to the U.S. business strategy outlined during JT's earlier acquisition of Vector Group.

She said CLEW would enable JTI to enter the U.S. nicotine pouch category, complement its existing cigarette portfolio and support a larger contribution from the American market and sustainable U.S. dollar cash flows over the medium to long term.

JT said the acquisition would be financed with existing cash and was not expected to materially affect its consolidated financial performance for fiscal 2026.

The purchase price and CLEW's financial results were not disclosed.

After $2.4 Billion Vector Deal, JTI Adds Nicotine Pouches to U.S. Business

In August 2024, JT announced an agreement to acquire Vector Group for $15 per share, representing approximately $2.4 billion in equity consideration.

The acquisition was completed on October 7, 2024, making Vector a wholly owned JT subsidiary and ending its listing on the New York Stock Exchange.

Vector's operations included cigarette manufacturer Liggett and value-priced brands such as Montego and Eagle. The transaction expanded JT's presence in the lower-priced U.S. cigarette market and added to its distribution network.

According to JTI LIGGETT's website, the company is now the fourth-largest cigarette manufacturer in the United States, with more than 8% market share and products distributed through more than 160,000 retail stores.

It also reports three U.S. production facilities and more than 900 full-time employees.

JT's U.S. cigarette business has continued to gain market share. In the first half of 2026, sales volume for the LD brand increased 32.6% year on year, while the group's estimated share of the U.S. combustible tobacco market reached 8.6%, according to its financial disclosures.

At the 2026 NACS Show in Las Vegas in October, 2Firsts observed JTI LIGGETT highlighting its value-priced cigarette brands, including LD, Montego and Eagle.

Asked about nicotine pouches, JTI LIGGETT booth staff told 2Firsts that the company had not yet launched products in the category in the United States. They did not provide details of future plans.

JT already operates internationally in nicotine pouches through Nordic Spirit, which is sold in the United Kingdom and other markets.

In the U.S. heated tobacco business, JT has also established a partnership with Altria Group. The companies formed Horizon Innovations in 2022 to pursue regulatory clearance and future commercialization of Ploom heated tobacco devices and Marlboro-branded heated tobacco sticks. Ploom devices were displayed at Altria's booth during the 2026 NACS Show.

The CLEW acquisition adds nicotine pouches to JTI LIGGETT's U.S. product portfolio.

However, the company's existing retail footprint of more than 160,000 stores relates to its cigarette operations, not confirmed CLEW distribution. JT has not disclosed plans to introduce CLEW through those outlets.

CLEW Holds PMTA Asset but Has No FDA Marketing Authorization

CLEW offers tobacco leaf-free nicotine pouches across several flavors and nicotine strengths.

On June 6, 2024, Nevcore announced that the U.S. Food and Drug Administration (FDA) had accepted a PMTA submission for CLEW nicotine pouches. The company described strengths ranging from 3 mg to 20 mg, without establishing that every variant was commercially available in the United States.

JT's latest acquisition includes a PMTA asset, but the company did not disclose the products covered, application identification numbers or current review status.

The Louisiana Office of Alcohol and Tobacco Control's vapor and alternative nicotine product directory, published on November 5, 2026, lists 19 CLEW stock-keeping units (SKUs) under Nevcore Innovations Inc. in the state's approved directory. Another 11 CLEW SKUs are excluded from the approved list after failing to complete renewal certification.

The entries cover flavors including Citrus, Original, Spearmint, Wintergreen, Blueberry and Cool Mint.

Some CLEW products in the state's approved directory carry an FDA status of "Under FDA review."

That designation reflects manufacturer-certified information in the state directory, rather than a federal marketing authorization. Failure to complete state-level renewal certification also does not, by itself, establish that an FDA PMTA has been denied.

As of November 12, 2026, the FDA's public list of authorized nicotine pouch products contained 67 products, including offerings under ZYN, on! and VELO. CLEW was not included.

FDA acceptance or review of a PMTA does not constitute authorization to market a product.

JT has not disclosed whether it will modify CLEW's existing PMTA submission, product range or manufacturing arrangements following the acquisition.

U.S. Nicotine Pouch Competition Grows as JT Weighs CLEW Expansion

The U.S. nicotine pouch market includes major international tobacco companies such as Philip Morris International (PMI), owner of ZYN; Altria Group, which owns on!; and British American Tobacco (BAT), whose portfolio includes VELO.

In January 2025, the FDA authorized the first 20 ZYN nicotine pouch products. Further authorizations followed, including 24 VELO products on October 30, 2026, bringing the total number of authorized nicotine pouch products to 67.

Through CLEW, JT is acquiring an existing product portfolio, a limited U.S. retail presence and a PMTA asset.

JTI LIGGETT, meanwhile, operates an established cigarette manufacturing and distribution business with a substantially larger retail footprint than the distribution presence currently disclosed for CLEW.

JT has not explained whether CLEW will use JTI LIGGETT's existing retail customers, sales teams or logistics network, nor has it announced a nationwide rollout target.

The company also did not disclose CLEW's manufacturing locations, production capacity, revenue or profitability.

JT's 2024 Vector acquisition expanded its U.S. cigarette operations. The CLEW transaction now adds nicotine pouches to that business, with future commercialization and distribution plans still subject to company decisions and applicable regulatory requirements.

Follow 2Firsts for continuing coverage of tobacco industry acquisitions, U.S. nicotine pouch distribution and regulatory developments in next-generation nicotine products.

Cover Image generated by AI


References:

  1. Japan Tobacco Inc. — JT Group Acquires a Nicotine Pouch Brand in the USA, November 12, 2026
  2. Japan Tobacco Inc. — JT Group to Acquire Vector Group Ltd., August 21, 2024
  3. Japan Tobacco Inc. — JT Group Completes Acquisition of Vector Group Ltd., October 7, 2024
  4. JTI — USA: JTI LIGGETT Company Profile and Retail Distribution
  5. 2Firsts — JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show, October 9, 2026
  6. Nevcore Innovations — CLEW Modern Oral Nicotine Pouches Receive FDA Acceptance for PMTA, June 6, 2024
  7. U.S. FDA — Nicotine Pouch Products Authorized by the FDA
  8. U.S. FDA — FDA Authorizes Marketing of 24 VELO Nicotine Pouches, October 30, 2026
  9. Louisiana Office of Alcohol and Tobacco Control — Vapor Product and Alternative Nicotine Product Directory, November 5, 2026
  10. 2Firsts — Altria Showcases Ploom, Marlboro Heated Tobacco Sticks and Non-Nicotine Energy Products at NACS Show 2026

2FIRSTS | How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
2FIRSTS | How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
www.2firsts.com

2FIRSTS | Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
2FIRSTS | Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
www.2firsts.com

Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
A decade-long study published in The Lancet Regional Health – Western Pacific found that heated tobacco product use in Japan increased from 0.1% in 2015 to 14.9% in 2025, although growth slowed after 2018. Switching from conventional cigarettes remained an important source of HTP uptake, while the contribution from previously non-current users increased. Approximately 56% of HTP users also smoked conventional cigarettes in 2025. Separate industry data show that Japan's heated tobacco sales reached 73.4 billion units in fiscal 2025, approaching conventional cigarette sales of 78.2 billion units.
SCIENCE
Nov.10
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Philip Morris International (PMI) is expanding the international footprint of BONDS by IQOS, its lower-priced heated tobacco platform. The company's third-quarter 2026 SEC filing shows that BONDS devices and BLENDS tobacco sticks were available in 15 markets at the end of September, up from eight at the end of June. In November, PMI announced plans to extend sales from three to 17 Japanese prefectures and introduced BONDS in Spain and Morocco. The platform uses ROUNDHEAT external heating technology and proprietary tobacco sticks, separate from the IQOS ILUMA system. In Japan, BONDS retails for ¥2,980, approximately 25% below ILUMA i ONE, while BLENDS costs ¥570 per pack. PMI management says BONDS targets cigarette smokers who have not adopted heated tobacco. Separate sales and revenue figures remain undisclosed.
company
Nov.06
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22